Precision Medicine
Leverage the depth of our large registries and biosamples to identify specific patient phenotypes and analyze disease progression & genetic disposition
Find the Right Biomarker for Your Product
Target RWE links complete longitudinal registry data with our robust, high-quality biorepository of samples collected along the patient journey to support precision medicine analyses. Serum, whole blood, plasma, skin tape strips, and saliva samples are collected from 10,000+ enrolled patients with 5+ years of clinical follow-up, driving meaningful study design and recruitment tailored to partner needs.
Connect Our Large Biorepository of Samples to Your Precision Medicine Strategies
Combined with Target RWE's registries, our biorepository samples can be instrumental in genetic and bio-marker identification for specific patient populations, such as those with rapid disease progression or to predict treatment response. Our curation of relevant clinical data points across structured and unstructured data including imaging, procedures, and clinician notes, linked with our biorepository, equips us to meet your specific use cases. Our samples are available to support research for:
Genome Sequencing
Diagnostics Assay Development & Validation
Genotyping
Biomarker Characterizations
Investigate Hypotheses with Ready-to-Analyze Biosamples
Target RWE biosamples are collected, handled, and stored according to validated standard operating procedures and meet robust quality requirements. Our samples have been collected per patient at various time points before and after a disease progression-defining events over 71+ months of clinical follow-up. Disease-specific patient-reported outcomes are also available at multiple time points of the patient journey.
Types of Biosamples
Collected Include:
-
Serum
-
Whole Blood
-
Plasma
-
Skin Tape Strips
-
Saliva
Integrate Precision Medicine into Your Drug Development Program
Target RWE’s predictive analytics paired with our causal inference capabilities set the foundation for our approach to generating novel precision medicine insights. More than 71 months of clinical disease progression data with all relevant procedures and protocol-driven biospecimen collection enables you to:
-
Validate assays
-
Identify drug candidates
-
Identify patient phenotypes
Target RWE is uniquely positioned to meet your observational-genomic research needs by unifying intelligently curated real-world evidence, biosamples, and principled epidemiologic methods.
[ "437" ]
